Literature DB >> 24831102

Physician and nonphysician health-care provider perspectives on resuscitation of suspected drug-related out-of-hospital cardiac arrest.

Allison C Koller, David D Salcido, James J Menegazzi.   

Abstract

INTRODUCTION: In the United States, out-of-hospital cardiac arrest from drug overdose (OD-OHCA) caused over 38,000 deaths in 2010. A study in Pittsburgh found that OD-OHCA patients differed demographically and in the resuscitation treatments they received, despite identical AHA resuscitation guidelines. We hypothesized that health-care provider perceptions affect decision-making in the treatment of OD-OHCA versus non-OD OHCA.
METHODS: We conducted this survey at the National Association of EMS Physicians 2013 Scientific Assembly. Physicians and non-physician health-care providers were given one of two surveys containing 19 questions pertaining to the respondents' affiliated EMS agencies, the estimated proportion of OD-OHCA as well as the drugs involved, and the respondents' belief about the treatments for OD versus non-OD OHCA.
RESULTS: One hundred ninety-three respondents participated in this survey. Of the 193, 144 (75%) were physicians and 49 (25%) were nonphysicians. Seventy-nine percent of physicians identified current status as a medical director and 76% of nonphysicians identified as a paramedic. Participants estimated the average monthly proportion of all OHCA due to OD to be 9.4%. Participants ranked opioids, alcohol, antidepressants, and benzodiazepines as the most commonly utilized agents in OD-OHCA. The majority of physicians (42%) felt that the incidence of OD-OHCA was not changing while the majority of nonphysicians (53%) felt the incidence was increasing. Eighty-four percent of all respondents reported the use of naloxone during OD-OHCA resuscitation, while 13% reported administering naloxone during non-OD OHCA resuscitation. Eighty-nine percent of physicians and 67% of nonphysicians indicated that OD-OHCA patients had different demographics than non-OD OHCA, with primary reported differences being age, comorbidities, and socioeconomic status. Sixty-three percent of physicians and 71% of nonphysicians felt that OD-OHCA patients should be treated differently, with primary differences being the incorporation of etiology-specific treatments, performing different CPR with a focus on airway support, and transporting earlier.
CONCLUSIONS: When surveyed, physicians and nonphysician providers report perceiving OD-OHCA treatment, outcomes, and patient demographics differently than non-OD OHCA and making different treatment decisions based on these perceptions. This may result in etiology-oriented resuscitation in the out-of-hospital setting, despite the lack of OD-specific resuscitation guidelines.

Entities:  

Keywords:  EMS system; cardiac arrest; drug overdose; resuscitation

Mesh:

Year:  2014        PMID: 24831102     DOI: 10.3109/10903127.2014.897780

Source DB:  PubMed          Journal:  Prehosp Emerg Care        ISSN: 1090-3127            Impact factor:   3.077


  4 in total

1.  Recreational drug overdose-related cardiac arrests: break on through to the other side.

Authors:  Jonathan Elmer; Michael J Lynch; Jeffrey Kristan; Patrick Morgan; Stacy J Gerstel; Clifton W Callaway; Jon C Rittenberger
Journal:  Resuscitation       Date:  2015-02-04       Impact factor: 5.262

2.  Out-of-hospital cardiac arrest survival in drug-related versus cardiac causes in Ontario: A retrospective cohort study.

Authors:  Aaron M Orkin; Chun Zhan; Jason E Buick; Ian R Drennan; Michelle Klaiman; Pamela Leece; Laurie J Morrison
Journal:  PLoS One       Date:  2017-04-26       Impact factor: 3.240

3.  Administration of Naloxone by Prehospital Personnel: A Retrospective Analysis.

Authors:  Kaitlin M Bowers; Judd Shelton; Eric Cortez; Robert Lowe; John Casey; Andrew Little
Journal:  Cureus       Date:  2019-09-09

4.  A qualitative analysis of physician decision making in the use of extracorporeal cardiopulmonary resuscitation for refractory cardiac arrest.

Authors:  Joseph E Tonna; Heather T Keenan; Charlene Weir
Journal:  Resusc Plus       Date:  2022-07-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.